Frontiers in Clinical Drug Research - CNS and Neurological Disorders

View Sample

Frontiers in Clinical Drug Research - CNS and Neurological Disorders

Volume 6

eBook: US $89 Special Offer (PDF + Printed Copy): US $176
Printed Copy: US $131
Library License: US $356
ISSN: 2451-8883 (Print)
ISSN: 2214-7527 (Online)
ISBN: 978-1-68108-608-8 (Print)
ISBN: 978-1-68108-607-1 (Online)
Year of Publication: 2018
DOI: 10.2174/97816810860711180601

Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.

The sixth volume of this series features reviews that cover the following topics:

- Depression, Insomnia and Atypical Antidepressants
- Combination Therapy of Hypothermia for Hypoxic Encephalopathy in Neonates
- Development of A “Theranostic Nano-Bullet” for Tinnitus
- Dexmedetomidine: From Basic Science to Clinical Application of Brain Protection
- Protein Misfolding, Aggregation, Amyloid Formation in Neurodegenerative Diseases

Indexed in: Scopus, EMBASE, EBSCO.

eBook: US $89 Special Offer: US $176 Printed Copy: US $131 Library License: US $356

Frontiers in Clinical Drug Research - CNS and Neurological Disorders presents recent important developments in the treatment of central nervous system (CNS) and nerve disorders. The book is a valuable resource for pharmaceutical scientists, postgraduate students and researchers seeking recent information for developing clinical trials and devising research plans in the field of neurology. The chapters are written by eminent authorities in the field. The contents of this volume cover recent researches on depression and insomnia, combination therapy of hypothermia, tinnitus, and protein misfolding.

I hope that the readers will find these reviews valuable and thought provoking so that they may trigger further research in the quest for new and novel therapies against neurological disorders.

I am grateful for the timely efforts made by the editorial personnel, especially Mr. Mahmood Alam (Director Publications), and Mr. Shehzad Iqbal Naqvi (Senior Manager Publications) at Bentham Science Publishers.

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK